Physician profile
Taelor Baetz
NPI 1881385656
$1,417.08
in general payments reported to CMS, 2019-2025
21 companies · $256 in 2025
The $256 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $201 · 2024: $961 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,417.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $357.52 | 2023-2025 | Airsupra, Fasenra, Breztri |
| Regeneron Healthcare Solutions, INC. | $163.56 | 2023-2024 | Dupixent |
| Genzyme Corporation | $131.66 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.83 | 2024-2025 | Ofev, Jardiance |
| Actelion Pharmaceuticals US, INC. | $109.65 | 2023-2024 | Uptravi |
| Glaxosmithkline, LLC. | $99.21 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Mylan Specialty L.P. | $74.83 | 2023-2024 | Yupelri |
| Grifols USA, LLC | $45.31 | 2024-2025 | Prolastin-C Liquid |
| Exact Sciences Corporation | $37.43 | 2023-2025 | Cologuard Collection Kit |
| Viatris Specialty LLC | $37.10 | 2025 | Yupelri |
| Novo Nordisk INC | $32.31 | 2024-2025 | Ozempic |
| Viiv Healthcare Company | $30.81 | 2025 | Cabenuva |
| Baxter Healthcare | $29.38 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Lilly USA, LLC | $27.08 | 2024 | Zepbound, Mounjaro |
| Avadel Cns Pharmaceuticals, LLC | $20.78 | 2024 | Lumryz |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.26 | 2024 | Xolair |
| Phathom Pharmaceuticals, INC. | $16.94 | 2024 | Voquezna |
| Kowa Pharmaceuticals America, INC. | $15.50 | 2024 | Zoryve |
| Axsome Therapeutics, INC. | $14.57 | 2024 | Sunosi |
| Electromed, INC. | $14.25 | 2025 | Smartvest |
| Philips North America LLC | $14.10 | 2024 | (Ak6) Vest Therapy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taelor Baetz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.